| |
siRNA Id: | aspsirna1814
|
siRNA Name: | Ds10/11
|
Gene: | Coagulation factor III (thromboplastin, tissue factor) (F3) /CD142 |
Disease: | Malignant melanoma |
Wild allele/target (5'->3'): | GCGCUUCAGGCACUACAAAUA
|
Mutant allele/target (5'->3'): | GCGCUUCAGCGACUACAAAUA
|
Target Mutation: | c.489G>A,p.Arg163=
|
Wild siRNA (As strand): | CGCGAAGUCCGUGAUGUUUAU
|
ASP-siRNA (As strand): | CGCGAAGUCGCUGAUGUUUAU
|
Mismatch position in siRNA: | G12C,C11G |
Mutant allele (5'->3'): | GCGCUUCAGCGACUACAAAUA
|
ASP-siRNA (As strand): | CGCGAAGUCGCUGAUGUUUAU
|
ASP-siRNA efficacy for mutant allele: | NA
|
Wild allele (5'->3'): | GCGCUUCAGGCACUACAAAUA
|
ASP-siRNA (As strand): | CGCGAAGUCGCUGAUGUUUAU
|
ASP-siRNA efficacy for wild allele: | NA
|
Percentage discrimination for ASP-siRNA: | NA
|
Wild allele (5'->3'): | GCGCUUCAGGCACUACAAAUA
|
Wild siRNA (As strand): | CGCGAAGUCCGUGAUGUUUAU
|
Wild sirna efficacy for wild allele: | NA
|
Wild allele (5'->3'): | GCGCUUCAGGCACUACAAAUA
|
ASP-siRNA (As strand): | CGCGAAGUCGCUGAUGUUUAU
|
Wild sirna efficacy for mutant allele: | NA
|
Percentage discrimination for wild siRNA: | NA
|
Concentration: | 100nM |
Orientation: | Double strand |
Mismatch in: | siRNA |
UniProt ID: | Q99081 |
Target sequence: | AGGTGGCCGGCGCTTCAGGCACTACAAATACTGTGG |
Genbank Accesion: | NM_001178096.1 |
Cell-line: | HaCaT |
Experimental technique used: | Northern blot |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Glen Research,PerSeptive Biosystems |
Post-transfection duration: | 48 hours |
OMID ID: | 134390 |
KEGG disease ID: | NA |
Reference: | 12527766 |
| |
siRNA Id: | aspsirna1814
|
siRNA Name: | siCD46
|
Gene: | Complement regulatory protein (CD46) |
Disease: | Hemolytic uremic syndrome |
Wild allele/target (5'->3'): | CUUAUUGGAGAGAGCACGA
|
Mutant allele/target (5'->3'): | CUUAUUGGAAAGAGCACGA
|
Target Mutation: | c.104G>A, p.Cys35Tyr
|
Wild siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
Mismatch position in siRNA: | C:A clash |
Mutant allele (5'->3'): | CUUAUUGGAAAGAGCACGA
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
ASP-siRNA efficacy for mutant allele: | 27
|
Wild allele (5'->3'): | CUUAUUGGAGAGAGCACGA
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
ASP-siRNA efficacy for wild allele: | 93
|
Percentage discrimination for ASP-siRNA: | 66
|
Wild allele (5'->3'): | CUUAUUGGAGAGAGCACGA
|
Wild siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
Wild sirna efficacy for wild allele: | 93
|
Wild allele (5'->3'): | CUUAUUGGAGAGAGCACGA
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
Wild sirna efficacy for mutant allele: | 27
|
Percentage discrimination for wild siRNA: | 66
|
Concentration: | 13nM |
Orientation: | Sense |
Mismatch in: | siRNA |
UniProt ID: | P15529 |
Target sequence: | GCCCCCAATATGTGAAAAG |
Genbank Accesion: | NM_002389.4 |
Cell-line: | HEK293 |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Dharmacon |
Post-transfection duration: | 24 hours |
OMID ID: | 120920 |
KEGG disease ID: | H00106, H0027 |
Reference: | 15781493 |
.
.
.
.
.
.
.
.
.
.
.
.
.
.